Research and Discovery at the College of Arts & Sciences
From here, it's possible. As the academic heart of Texas Tech University with more than 11,000 undergraduate and graduate students, and more than 450 faculty members, the College of Arts & Sciences cultivates a powerful drive to discover the promises of tomorrow. From our astrophysicists investigating the life cycles of stars, to microbiologists testing COVID-19 samples, to sociologists analyzing how to predict the economic impacts of elections, the impact of our research is profound. The diverse collection of research within the College of Arts & Sciences stretches an impressive span of fields and impacts nearly every walk of life.
Iber Chronicles Life of Gabe Rivera
Jorge Iber, associate dean in the College of Arts & Sciences and professor in the Department of History, has published his latest sports biography, “Señor Sack: The Life of Gabe Rivera” (Texas Tech University Press, August 2021), about the former Texas Tech All-American defensive lineman. Read the full article here.
Mechref Expands Brain Cancer Research to Neurodegenerative Diseases
Yehia Mechref, a Horn Distinguished Professor in the Department of Chemistry & Biochemistry, and associate vice president of research and innovation, is known wordwide for his breast cancer research, which is supported by an R01 research grant from the National Institutes of Health (NIH) that has been renewed twice — an unprecedented achievement at Texas Tech. Mechref specializes in studying glycans, or biological sugars, which are an important component of the cellular recognition pathways that regulate basic biological function — for better or for worse. But unlocking the inner workings of cancer isn't Mechref's only ongoing project. The methods he uses to do that work also enable potentially life-changing research in other areas. “We will still be looking at the breast cancer-brain metastasis, but now we are expanding it and using our technology to look at traumatic brain injuries (TBI), Alzheimer's disease and neurodegenerative diseases,” Mechref said.